Yin, Li
Dinasarapu, Ashok R.
Borkar, Samiksha A.
Chang, Kai-Fen
De Paris, Kristina
Kim-Chang, Julie J.
Sleasman, John W.
Goodenow, Maureen M.
Funding for this research was provided by:
National Institutes of Health (U01-DA044571, R01-DA031017)
National Institutes of Health
Article History
Received: 9 February 2022
Accepted: 20 April 2022
First Online: 31 May 2022
Declarations
:
: All participants provided consent for enrollment in Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions protocol 071/101, <i>Assessment of Inflammatory Markers Associated with Neurocognitive Impairment in HIV-infected Adolescents</i> at their individual sites (ClinicalTrials.gov Identifier NCT00683579). Approval to analyze the biorepository samples from this study was obtained from the IRB of Duke University, <i>Consequences of Marijuana Use on Inflammatory pathways in HIV-Infected Youth,</i> (Pro00100780), as well as the IRB of the National Institute of Health (18-NIAID-00677).
: Not applicable.
: The authors declare that they have no competing interests.